HIGHLIGHTS
- who: Van Hung Nguyen and Bertrand Roy from the Influenza in Canada have published the research: Modelling the Economic Impact of lnfluenza Vaccine Programs with the Cell-Based Quadrivalent Influenza Vaccine and Adjuvanted Trivalent Influenza Vaccine in Canada, in the Journal: Vaccines 2022, 1257 of 16/05/2022
- what: In the analysis , the authors assumed the same VE for both vaccines and therefore did not directly assess the differences between identical scenarios containing HD-QIV versus aTIV. This analysis has shown that vaccination of 6-month- to 64-year-olds with a cell-based QIV . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.